• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Namepulse generator, permanent, implantable
Generic Namepulse generator, permanent, implantable
St. Jude Medical, Inc.
15900 valley view court
sylmar, CA 91342
PMA NumberP880086
Supplement NumberS174
Date Received01/22/2009
Decision Date07/15/2009
Product Code
NVZ[ Registered Establishments with NVZ ]
Advisory Committee Cardiovascular
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications/material
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the accent / accent rf implantable pulse generators and anthem / anthem rf crt-ps. The device, as modified, will be marketed under the trade name accent / accent rf implantable pulse generators and anthem / anthem rf crt-ps. The device is indicated for: 1) maintaining synchrony of the left and right ventricles in patients who have undergonean av nodal ablation for chronic atrial fibrillation and have nyha class ii or iii heart failure. 2) the reduction of the symptoms of moderate to severe heart failure (nyha class iiior iv) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction <=35% and a prolonged qrsduration. Implantation of accent, accent rf, anthem and anthem rf devices is indicated in one or more of the following permanent conditions:a) syncopeb) presyncopec) fatigued) disorientation due to arrhythmia/ bradycardiae) or combination of those symptoms. Rate-modulated pacing is indicated for patients with chronotropic incompetence, and for those who would benefit from increased stimulation rates concurrent with physical activity. Dual-chamber pacing (accent model pm2110, accent rf model pm2210, anthem and anthem rf devices only) is indicated for those patients exhibiting:a) sick sinus syndromeb) chronic, symptomatic second- and third-degree av blockc) recurrent adams-stokes syndromed) symptomatic bilateral bundle branch block when tachyarrhythmia and other causeshave been ruled out. Atrial pacing is indicated for patients with sinus node dysfunction and normal av andintraventricular conduction systems. Ventricular pacing is indicated for patients with significant bradycardia and:a) normal sinus rhythm with only rare episodes of a-v block or sinus arrestb) chronic atrial fibrillationc) severe physical disability. (see approval order for additional approval information).